CStone Pharmaceuticals (2616.HK)

HKD 2.39

(-6.64%)

Inventory Summary of CStone Pharmaceuticals

  • CStone Pharmaceuticals's latest annual inventory in 2023 was 108.82 Million CNY , up 390.48% from previous year.
  • CStone Pharmaceuticals's latest quarterly inventory in 2024 Q1 was 181.53 Million CNY , up 66.8% from previous quarter.
  • CStone Pharmaceuticals reported annual inventory of 22.18 Million CNY in 2022, down -63.84% from previous year.
  • CStone Pharmaceuticals reported annual inventory of 61.36 Million CNY in 2021, down 0.0% from previous year.
  • CStone Pharmaceuticals reported quarterly inventory of 181.53 Million CNY for 2024 Q2, down 0.0% from previous quarter.
  • CStone Pharmaceuticals reported quarterly inventory of 19.57 Million CNY for 2023 Q1, down -11.77% from previous quarter.

Annual Inventory Chart of CStone Pharmaceuticals (2023 - 2016)

Historical Annual Inventory of CStone Pharmaceuticals (2023 - 2016)

Year Inventory Inventory Growth
2023 108.82 Million CNY 390.48%
2022 22.18 Million CNY -63.84%
2021 61.36 Million CNY 0.0%
2020 - CNY 0.0%
2019 - CNY 0.0%
2018 - CNY 0.0%
2017 - CNY 0.0%
2016 - CNY 0.0%

Peer Inventory Comparison of CStone Pharmaceuticals

Name Inventory Inventory Difference
Uni-Bio Science Group Limited 36.39 Million HKD -199.044%
CK Life Sciences Int'l., (Holdings) Inc. 1.2 Billion HKD 90.965%